Faculty Disclosures
| Stanley H. Appel, MD, FAAN |
Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics. |
| Paul J. Eslinger, PhD |
No disclosure on file
|
| Stuart A. Lipton, MD, PhD, FAAN |
Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Deerfield Management. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Panorama Research, Inc.. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Circumvent Therapeutics, Inc.. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Harvard Medical School/Boston Children's Hostpial. Dr. Lipton has stock in EuMentis Therapeutics, Inc.. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from CIRM California Institute for Regenerative Medicine. The institution of Dr. Lipton has received research support from TRDRP California Tobacco Related Research/UCOP. The institution of Dr. Lipton has received research support from Circumvent Pharmaceuticals. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has received intellectual property interests from a discovery or technology relating to health care. Dr. Lipton has a non-compensated relationship as a Associate Editor with Neuron (Cell Press) that is relevant to AAN interests or activities. |
| Erik P. Pioro, MD, DPhil, FAAN |
Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc.. |
| Richard A. Smith, MD |
Dr. Smith has received personal compensation for serving as an employee of Center for Neurologic Study. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Inventor with Ionis Pharmaceutical. |
| Murray Grossman, MD, FAAN |
Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH. |
| Jeffrey D. Rothstein, MD, PhD |
Dr. Rothstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Expansion Therapeutics. Dr. Rothstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal Clinical Investigation. The institution of Dr. Rothstein has received research support from ALSA. The institution of Dr. Rothstein has received research support from MDA. The institution of Dr. Rothstein has received research support from F Prime. The institution of Dr. Rothstein has received research support from Target ALS. The institution of Dr. Rothstein has received research support from Chan Zuckerberg Initiative. The institution of Dr. Rothstein has received research support from Dept of Defense. Dr. Rothstein has received intellectual property interests from a discovery or technology relating to health care. |
| Albert A. Yen, MD |
No disclosure on file
|
| Don Cleveland, PhD |
No disclosure on file
|
| Timothy M. Miller, MD, PhD |
Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen IDEC. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. Dr. Miller has received intellectual property interests from a discovery or technology relating to health care. |
| Pablo Bonardo, MD |
Dr. Bonardo has nothing to disclose. |
| Sheryl Martin-Schild, MD, PhD, FAAN |
No disclosure on file
|
| Jenny Henkel, PhD |
No disclosure on file
|
| Weihua Zhao, MD |
No disclosure on file
|
| Koji Yamanaka, MD, PhD |
No disclosure on file
|
|
No disclosure on file
|
| Corey McMillan, PhD |
Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH. |
| David R. Beers, PhD |
No disclosure on file
|
| Qin Xiao, MD, PhD |
No disclosure on file
|
| Dongxian Zhang, PhD |
No disclosure on file
|
| Brett Monia, PhD |
No disclosure on file
|
| Genevieve A. Laforet, MD, PhD |
No disclosure on file
|
| Jacqueline Rick |
No disclosure on file
|
| Daniel Weintraub |
Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care. |
| Masaki Kobayashi, MD |
No disclosure on file
|
| Digvijaya D. Navalkele, MD |
Dr. Navalkele has nothing to disclose. |
| Gabriela Raina |
No disclosure on file
|
| Katya Rascovsky |
No disclosure on file
|
| Oscar Martinez, MD |
No disclosure on file
|
| Dominique Monlezun, Jr |
No disclosure on file
|
| Laurie A. Schluter, RN, MSN, FNP |
No disclosure on file
|
| Kevin S. Attenhofer, MD |
No disclosure on file
|
| Alyana Samai |
No disclosure on file
|
| Emily Brereton |
No disclosure on file
|
| Arvind Narayana |
Arvind Narayana has received personal compensation for serving as an employee of Akcea Therapeutics. Arvind Narayana has received stock or an ownership interest from Akcea Therapeutics. |
| Maria S. Pacha |
No disclosure on file
|
| Veronica A. Tkachuk |
Veronica A. Tkachuk has nothing to disclose. |
| Celeste Di Johnson |
No disclosure on file
|
| Jaime A. Shoup, MD |
Dr. Shoup has nothing to disclose. |
| Marianela Elisa Crespo Arizmendi |
No disclosure on file
|
| DE Frank |
No disclosure on file
|
| Natalie J. Engmann, PhD |
No disclosure on file
|